1CUMBERBATCH MG, ROTA M, CATTO JW, et al. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks[J].Eur Urol,2015. Sep 9. pii: S0302-2838(15)00778-2. doi: 10.1016/j.eururo.2015.08.033. [Epub ahead of print].
2ZNAOR A, LORTET-TIEULENT J, LAVERSANNE M, et al. International variations and trends in renal cell carcinoma incidence and mortality[J].Eur Urol,2015,67(3):519-530.
3CHAVAN S, BRAY F, LORTET-TIEULENT J, et al. International variations in bladder cancer incidence and mortality[J].Eur Urol,2014,66(1):59-73.
4MACLURE M, KATZ RB, BRYANT MS, et al. Elevated blood levels of carcinogens in passive smokers[J].Am J Public Health,1989,79(10):1381-1384.
6VAN ROEKEL EH, CHENG KK, JAMES ND, et al. Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis[J].Int J Cancer,2013,133(2):446-454.
7RINK M, XYLINAS E, MARGULIS V, et al. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy[J].Eur Urol,2013,63(6):1082-1090.
8ZHANG ZF, SARKIS AS, CORDON-CARDO C, et al. Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer[J].Cancer Epidemiol Biomarkers Prev,1994,3(1):19-24.
9ZHANG ZF, SHU XM, CORDON-CARDO C, et al. Cigarette smoking and chromosome 9 alterations in bladder cancer[J].Cancer Epidemiol Biomarkers Prev,1997,6(5):321-326.
10SOPORI M. Effects of cigarette smoke on the immune system[J].Nat Rev Immunol,2002,2(5):372-377.
4EWARTTOLAND A, BRIASSOULI P, DE KONING JP, et al. Identification of STK6/STK15 as a candidate low-penetrance tumorsusceptibility gene in mouse and human[J]. Nat Genet, 2003,34 (4) : 403-412.
5MIAO X,SUN T,WANG Y,et al. Functional STK15 Phe31 lie polymorphism is associated with the occurrence and advanced disease status of esophageal squamous cell carcinoma[J]. Cancer Res, 2004, 64(8) : 2680-2683.
6SEN S, ZHOU H, ZHANG RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer[J].J Natl Cancer Inst,2002,94(17) : 1320-1329.
7SCHULTZ IJ,KIEMENEY LA,ROELOFS R,et al. The prognostic role of the STK15 TglA polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinoma[J].Anticancer Res. 2007,27 (2) : 1025-1030.
8WANG R,WANG JH,CHU XY,et al. Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance[J]. Chn Biochem. 2009,42(7-8) :641-647.
9CHEN SS, CHANG PC, CHENG YW, ct al. Suppression of the STK15 oncogcnic activity requires a transactivation-independent P53 function[J]. EMBO J,2002,21(17) : 4491-4499.
10HAMMERSCHMIED CG,STOEHR R,WALTER B,et al. Role of the STK15 Phe31Ile polymorphism in renal cell carcinoma. Oncol Rep[J]. 2007,17(1):3-7.
